Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Quantitative Microbial Risk Assessment of Pharmaceutical Products

Mostafa Essam Eissa
PDA Journal of Pharmaceutical Science and Technology May 2017, 71 (3) 245-251; DOI: https://doi.org/10.5731/pdajpst.2016.007047
Mostafa Essam Eissa
HIKMA Pharma for Pharmaceutical Industry, 2nd Industrial Zone, 1st Plot, 6th of October City, Giza, Egypt, P.O. 13311
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mostafaessameissa@yahoo.com
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 71 no. 3 245-251
DOI 
https://doi.org/10.5731/pdajpst.2016.007047
PubMed 
27974628

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online May 26, 2017.

Article Versions

  • previous version (December 14, 2016 - 05:03).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2017

Author Information

  1. Mostafa Essam Eissa*
  1. HIKMA Pharma for Pharmaceutical Industry, 2nd Industrial Zone, 1st Plot, 6th of October City, Giza, Egypt, P.O. 13311
  1. ↵* Corresponding Author: Mostafa Essam Eissa, Quality Compliance Department, Hikma Pharma Pharmaceutical Company, Egypt. Telephone: +20100 615 4853; e-mail: mostafaessameissa{at}yahoo.com
View Full Text

Cited By...

  • 6 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A structure-dependent ratiometric fluorescence sensor based on metal-organic framework for detection of 2,6-pyridinedicarboxylic acid
    Li Chen, Donghao Liu, Limin Zheng, Simin Yi, Hua He
    Analytical and Bioanalytical Chemistry 2021 413 16
  • A novel eco-friendly green approach to produce particalized eggshell membrane (PEM) for skin health applications
    Garima Kulshreshtha, Tamer A. E. Ahmed, Ling Wu, Ty Diep, Maxwell T. Hincke
    Biomaterials Science 2020 8 19
  • Skin antiseptics in healthcare facilities: is a targeted approach necessary?
    Timothy L. Wiemken
    BMC Public Health 2019 19 1
  • Self-microemulsifying system of an ethanolic extract of Heliopsis longipes root for enhanced solubility and release of affinin
    Dailenys Marrero-Morfa, César Ibarra-Alvarado, Francisco J. Luna-Vázquez, Miriam Estévez, Eremy Miranda Ledesma, Alejandra Rojas-Molina, Carlos T. Quirino-Barreda
    AAPS Open 2023 9 1
  • Dosage Forms, Formulation Developments and Regulations
    Amal Kumar Dhara, Pranab Kumar Bandyopadhyay, Amit Kumar Nayak
    2024
  • Trending Perspective in Quality Control Monitoring and Investigation of Some Properties of Active Pharmaceutical Ingredient
    Mostafa Essam Ahmed Mostafa Eissa
    Asian Science Bulletin 2024 2 1
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 71 (3)
PDA Journal of Pharmaceutical Science and Technology
Vol. 71, Issue 3
May/June 2017
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative Microbial Risk Assessment of Pharmaceutical Products
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Quantitative Microbial Risk Assessment of Pharmaceutical Products
Mostafa Essam Eissa
PDA Journal of Pharmaceutical Science and Technology May 2017, 71 (3) 245-251; DOI: 10.5731/pdajpst.2016.007047

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quantitative Microbial Risk Assessment of Pharmaceutical Products
Mostafa Essam Eissa
PDA Journal of Pharmaceutical Science and Technology May 2017, 71 (3) 245-251; DOI: 10.5731/pdajpst.2016.007047
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Principles for the Risk Assessment from a Microbiologically Contaminated Batch
    • Detectability of Microbiologically Defective Samples (Pdet)
    • Severity and Frequency of Microbial Contaminant in Batch [(Σ Pinf)/N]
    • The Risk Probability Index and the Product Hazard Evaluation (Pri)
    • Conclusion
    • Conflict of Interest Declaration
    • Reference
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
  • Expanding the Use of Moist Heat for Terminal Sterilization
Show more Commentary

Similar Articles

Keywords

  • Microbiological quality
  • GMP
  • simulation study
  • Poisson distribution
  • Uncertainty Factor
  • dose-response model of infection

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire